Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through ...

Researchers are looking at ways to boost the performance and lower the environmental impact of millions of inhalers used for treating asthma and COPD. Working with drug manufacturer Kindeva, ...

“Asthma is a significant public health concern ... version of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri. This new propellant, HFO-1234ze, boasts a near-zero global ...

But few would suspect that a critical medical device for millions of people with asthma and COPD—asthma inhalers—could be ...

Inhaled steroids reduce and prevent inflammation, swelling, and mucus build-up in your airways and lungs to help prevent asthma attacks and help you breathe easier. But not everyone with asthma ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

Qualcomm and its rival Propeller are emerging as the tech companies to partner with in the development of smart inhalers. Virtually all the companies active in the asthma and COPD markets have ...

Although COPD and asthma share similarities, recognising their differences is essential for accurate diagnosis and treatment.

Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary ...